ArticleNumber 108
Author Blaeschke, Franziska
Apfelbeck, Antonia
Feuchtinger, Tobias
Willier, Semjon
Kaeuferle, Theresa
Rataj, Felicitas
Kobold, Sebastian
Lepenies, Mareike
Majzner, Robbie G.
Stenger, Dana
Benmebarek, Mohamed-Reda
Ortner, Eva
Busch, Dirk H.
Cadilha, Bruno L.
Mahdawi, Jasmin
Habjan, Nicola
Author_xml – sequence: 1
  givenname: Franziska
  surname: Blaeschke
  fullname: Blaeschke, Franziska
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 2
  givenname: Dana
  surname: Stenger
  fullname: Stenger, Dana
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, German Cancer Consortium (DKTK), Partner Site Munich
– sequence: 3
  givenname: Antonia
  surname: Apfelbeck
  fullname: Apfelbeck, Antonia
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 4
  givenname: Bruno L.
  surname: Cadilha
  fullname: Cadilha, Bruno L.
  organization: Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich
– sequence: 5
  givenname: Mohamed-Reda
  surname: Benmebarek
  fullname: Benmebarek, Mohamed-Reda
  organization: Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich
– sequence: 6
  givenname: Jasmin
  surname: Mahdawi
  fullname: Mahdawi, Jasmin
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 7
  givenname: Eva
  surname: Ortner
  fullname: Ortner, Eva
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 8
  givenname: Mareike
  surname: Lepenies
  fullname: Lepenies, Mareike
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 9
  givenname: Nicola
  surname: Habjan
  fullname: Habjan, Nicola
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 10
  givenname: Felicitas
  surname: Rataj
  fullname: Rataj, Felicitas
  organization: Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich
– sequence: 11
  givenname: Semjon
  surname: Willier
  fullname: Willier, Semjon
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
– sequence: 12
  givenname: Theresa
  surname: Kaeuferle
  fullname: Kaeuferle, Theresa
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, National Center for Infection Research (DZIF)
– sequence: 13
  givenname: Robbie G.
  surname: Majzner
  fullname: Majzner, Robbie G.
  organization: Department of Pediatrics, Stanford University School of Medicine, Stanford Cancer Institute, Stanford University School of Medicine
– sequence: 14
  givenname: Dirk H.
  orcidid: 0000-0001-8713-093X
  surname: Busch
  fullname: Busch, Dirk H.
  organization: National Center for Infection Research (DZIF), Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, Focus Group “Clinical Cell Processing and Purification”, Institute for Advanced Study, TUM
– sequence: 15
  givenname: Sebastian
  surname: Kobold
  fullname: Kobold, Sebastian
  organization: German Cancer Consortium (DKTK), Partner Site Munich, Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich
– sequence: 16
  givenname: Tobias
  orcidid: 0000-0002-8517-9681
  surname: Feuchtinger
  fullname: Feuchtinger, Tobias
  email: tobias.feuchtinger@med.uni-muenchen.de
  organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, German Cancer Consortium (DKTK), Partner Site Munich, National Center for Infection Research (DZIF)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34088894$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_oH-CAInHhEhh_xfYFabWlUKkSCJWz5ThO6iVrL3ZSif56nKYLbQ_1ZfzxvK_GM3NcHPjgbVG8QfABAREfE0UURAUYVQBUyur2RXGEgdKKEcEOHuwPi9OUNpAXq5FE8lVxSLJUCEmPCr2a-q31o_N9qXOo1mdI5l27P2Fcrlc_yqvK2GEou8mb0QVfTmlWfD-r0MyI0lxb82sXnB8zk2ZiF8NonU-vi5edHpI9vY8nxc_zz1frr9Xlty8X69VlZRiFsaKWS2xbzBsqbUOMsEgC0Vi2RHDRGKhxyySWltGm7lpAjAElUCNSS5bfyElxsfi2QW_ULrqtjn9U0E7dXYTYKx1HZwardIc506hhhmtqTKdbqTnS3EitKQDOXp8Wr93UbG1rcoGiHh6ZPn7x7lr14UYJxAUFmQ3e3xvE8HuyaVRbl-YKam_DlBTOjQFGOZvRd0_QTZiiz6WaKQ5Q559m6u3DjP6lsu9kBsQCmBhSirZTxo167lVO0A0KgZrnRi1zo_LcqLu5UbdZip9I9-7PisgiShn2vY3_035G9RfXq9Jj
CitedBy_id crossref_primary_10_3389_fimmu_2022_883694
crossref_primary_10_1186_s12943_022_01561_5
crossref_primary_10_3389_fimmu_2023_1063454
crossref_primary_10_1136_jitc_2023_007829
crossref_primary_10_1016_j_blre_2024_101241
crossref_primary_10_3389_fonc_2022_832765
crossref_primary_10_2147_OTT_S274551
crossref_primary_10_1016_j_cell_2023_08_013
crossref_primary_10_1080_2162402X_2022_2163781
crossref_primary_10_1016_j_intimp_2025_114083
crossref_primary_10_3389_fimmu_2023_1265299
crossref_primary_10_1016_j_omton_2024_200815
crossref_primary_10_1007_s13402_022_00747_9
crossref_primary_10_3389_fimmu_2022_845499
crossref_primary_10_1371_journal_pone_0310430
crossref_primary_10_3389_fimmu_2022_869825
crossref_primary_10_1016_j_phrs_2023_107018
crossref_primary_10_1016_j_xcrm_2024_101421
crossref_primary_10_1038_s41392_022_01136_2
crossref_primary_10_1038_s41416_023_02332_9
Cites_doi 10.1158/0008-5472.CAN-15-2524
10.1182/blood-2017-02-769208
10.1158/1078-0432.CCR-20-1457
10.1158/1078-0432.CCR-17-0867
10.1158/1078-0432.CCR-13-0458
10.1182/blood-2004-11-4564
10.1056/NEJMoa1709866
10.1038/s41598-017-00462-8
10.18632/oncotarget.12357
10.1038/nbt.4195
10.1158/1078-0432.CCR-20-2085
10.1038/s41375-020-0793-1
10.3389/fimmu.2018.01955
10.1038/nature24649
10.1093/jnci/djv146
ContentType Journal Article
Copyright The Author(s) 2021
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1038/s41408-021-00499-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2044-5385
EndPage 6
ExternalDocumentID oai_doaj_org_article_af275a1b5c7a4ccfad9a71a7c9aa4002
PMC8178409
34088894
10_1038_s41408_021_00499_z
Genre Letter
Research Support, Non-U.S. Gov't
Correspondence
GroupedDBID 0R~
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EJD
EMOBN
FRP
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
KQ8
M1P
M48
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c540t-4e792ed27b49eb3c8e1903a29d3878bc062d5929e54b6fd0155043061369562d3
IEDL.DBID M48
ISSN 2044-5385
IngestDate Wed Aug 27 01:31:59 EDT 2025
Thu Aug 21 18:14:57 EDT 2025
Fri Sep 05 12:52:17 EDT 2025
Wed Aug 13 08:18:21 EDT 2025
Mon Jul 21 05:13:57 EDT 2025
Thu Apr 24 23:11:30 EDT 2025
Tue Jul 01 02:32:59 EDT 2025
Fri Feb 21 02:38:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-4e792ed27b49eb3c8e1903a29d3878bc062d5929e54b6fd0155043061369562d3
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
ObjectType-Article-2
content type line 23
ORCID 0000-0002-8517-9681
0000-0001-8713-093X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41408-021-00499-z
PMID 34088894
PQID 2537006550
PQPubID 2041967
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_af275a1b5c7a4ccfad9a71a7c9aa4002
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8178409
proquest_miscellaneous_2538054759
proquest_journals_2537006550
pubmed_primary_34088894
crossref_citationtrail_10_1038_s41408_021_00499_z
crossref_primary_10_1038_s41408_021_00499_z
springer_journals_10_1038_s41408_021_00499_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-06-04
PublicationDateYYYYMMDD 2021-06-04
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-06-04
  day: 04
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
PublicationTitle Blood cancer journal (New York)
PublicationTitleAbbrev Blood Cancer J
PublicationTitleAlternate Blood Cancer J
PublicationYear 2021
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Zhou (CR15) 2020; 26
Wartewig (CR14) 2017; 552
Rupp (CR13) 2017; 7
Straathof (CR10) 2005; 105
CR6
Rafiq (CR12) 2018; 36
Liu (CR9) 2020; 27
John (CR3) 2013; 19
Blaeschke (CR5) 2020; 34
Rataj (CR7) 2018; 9
Li (CR11) 2017; 23
Maude (CR2) 2018; 378
Feucht (CR4) 2016; 7
Liu (CR8) 2016; 76
Gardner (CR1) 2017; 129
SL Maude (499_CR2) 2018; 378
F Rataj (499_CR7) 2018; 9
T Wartewig (499_CR14) 2017; 552
X Liu (499_CR8) 2016; 76
LB John (499_CR3) 2013; 19
LJ Rupp (499_CR13) 2017; 7
499_CR6
KC Straathof (499_CR10) 2005; 105
KI Zhou (499_CR15) 2020; 26
RA Gardner (499_CR1) 2017; 129
S Rafiq (499_CR12) 2018; 36
S Li (499_CR11) 2017; 23
H Liu (499_CR9) 2020; 27
J Feucht (499_CR4) 2016; 7
F Blaeschke (499_CR5) 2020; 34
References_xml – volume: 76
  start-page: 1578
  year: 2016
  end-page: 1590
  ident: CR8
  article-title: A chimeric switch-receptor targeting PD1 augments the efficacy of second-generation CAR T cells in advanced solid tumors
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-2524
– volume: 129
  start-page: 3322
  year: 2017
  end-page: 3331
  ident: CR1
  article-title: Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
  publication-title: Blood
  doi: 10.1182/blood-2017-02-769208
– volume: 27
  start-page: 473
  year: 2020
  end-page: 484
  ident: CR9
  article-title: CD19-specific CAR T cells that express a PD-1/CD28 chimeric switch-receptor are effective in patients with PD-L1-positive B-cell lymphoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-1457
– volume: 23
  start-page: 6982
  year: 2017
  end-page: 6992
  ident: CR11
  article-title: Enhanced cancer immunotherapy by chimeric antigen receptor-modified T cells engineered to secrete checkpoint inhibitors
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-17-0867
– volume: 19
  start-page: 5636
  year: 2013
  end-page: 5646
  ident: CR3
  article-title: Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-13-0458
– volume: 105
  start-page: 4247
  year: 2005
  end-page: 4254
  ident: CR10
  article-title: An inducible caspase 9 safety switch for T-cell therapy
  publication-title: Blood
  doi: 10.1182/blood-2004-11-4564
– volume: 378
  start-page: 439
  year: 2018
  end-page: 448
  ident: CR2
  article-title: Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
  publication-title: N. Engl J. Med.
  doi: 10.1056/NEJMoa1709866
– volume: 7
  year: 2017
  ident: CR13
  article-title: CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-00462-8
– volume: 7
  start-page: 76902
  year: 2016
  end-page: 76919
  ident: CR4
  article-title: T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.12357
– volume: 36
  start-page: 847
  year: 2018
  end-page: 856
  ident: CR12
  article-title: Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.4195
– volume: 26
  start-page: 6453
  year: 2020
  end-page: 6463
  ident: CR15
  article-title: Spatial and temporal heterogeneity of PD-L1 expression and tumor mutational burden in gastroesophageal adenocarcinoma at baseline diagnosis and after chemotherapy
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-2085
– ident: CR6
– volume: 34
  start-page: 2607
  year: 2020
  end-page: 2620
  ident: CR5
  article-title: Leukemia-induced dysfunctional TIM-3(+)CD4(+) bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients
  publication-title: Leukemia
  doi: 10.1038/s41375-020-0793-1
– volume: 9
  start-page: 1955
  year: 2018
  ident: CR7
  article-title: PD1-CD28 fusion protein enables CD4+ T cell help for adoptive T cell therapy in models of pancreatic cancer and non-hodgkin lymphoma
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.01955
– volume: 552
  start-page: 121
  year: 2017
  end-page: 125
  ident: CR14
  article-title: PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
  publication-title: Nature
  doi: 10.1038/nature24649
– volume: 105
  start-page: 4247
  year: 2005
  ident: 499_CR10
  publication-title: Blood
  doi: 10.1182/blood-2004-11-4564
– volume: 26
  start-page: 6453
  year: 2020
  ident: 499_CR15
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-2085
– volume: 27
  start-page: 473
  year: 2020
  ident: 499_CR9
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-1457
– volume: 7
  year: 2017
  ident: 499_CR13
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-00462-8
– volume: 378
  start-page: 439
  year: 2018
  ident: 499_CR2
  publication-title: N. Engl J. Med.
  doi: 10.1056/NEJMoa1709866
– volume: 76
  start-page: 1578
  year: 2016
  ident: 499_CR8
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-2524
– volume: 552
  start-page: 121
  year: 2017
  ident: 499_CR14
  publication-title: Nature
  doi: 10.1038/nature24649
– ident: 499_CR6
  doi: 10.1093/jnci/djv146
– volume: 34
  start-page: 2607
  year: 2020
  ident: 499_CR5
  publication-title: Leukemia
  doi: 10.1038/s41375-020-0793-1
– volume: 7
  start-page: 76902
  year: 2016
  ident: 499_CR4
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.12357
– volume: 129
  start-page: 3322
  year: 2017
  ident: 499_CR1
  publication-title: Blood
  doi: 10.1182/blood-2017-02-769208
– volume: 9
  start-page: 1955
  year: 2018
  ident: 499_CR7
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.01955
– volume: 36
  start-page: 847
  year: 2018
  ident: 499_CR12
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.4195
– volume: 23
  start-page: 6982
  year: 2017
  ident: 499_CR11
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-17-0867
– volume: 19
  start-page: 5636
  year: 2013
  ident: 499_CR3
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-13-0458
SSID ssj0000561919
Score 2.3364456
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 108
SubjectTerms 13/31
13/44
631/250/251
631/67/1990/283/2125
692/699/1541/1990/283/2125
Antigens, CD19 - immunology
Biomedical and Life Sciences
Biomedicine
Cancer Research
CD28 Antigens - therapeutic use
Cell Line, Tumor
Correspondence
Hematology
Humans
Immunotherapy, Adoptive
Oncology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy
Programmed Cell Death 1 Receptor - therapeutic use
Receptors, IgE - immunology
Recombinant Fusion Proteins - pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHhAXxJtAQUbiBlbjV2wft1uqCqkIoVbqzXJsZ1lRZSt299Jf37GTXbo8L9ySeCKN5qH5Jp58BnirvMiVUVKluKWy7Txt2yZQrI2Bp6BYLDzbp5-ak3P58UJd3DrqK8-EDfTAg-EOfMe18qxVQXsZQuej9Zp5Haz3cqSRrG19q5kaWL2xMWB2_EumFuZgKbGVMDRPJBSYT693KlEh7P8dyvx1WPKnHdNSiI4fwP0RQZLJoPlDuJP6R3D3dNwjfwx-sp6VGaB-RtBsczo9Yhav4uaOczKdfCFnNH-0J7mwZeeQPAE_I5-PsNtDGUPQm-Hb1WLer1Amf1MjhdNh3i-fwPnxh7PpCR0PUqABAdmKyqQtT5HrVlpsnoNJCAOE5zYKo00b6oZHhTgpKdk2XSxtixS50jfYPvEonsJev-jTcyCyDYF1koXOaNn54BUCoKSFtil6k7oK2MaoLows4_mwi0tXdruFcYMjHDrCFUe46wrebd-5Gjg2_ip9mH21lcz82OUBRo0bo8b9K2oq2N942o1Ju3RcCZ0hmaoreLNdxnTL7vB9WqyLjEGUq5Wt4NkQGFtNBGpqjJUV6J2Q2VF1d6Wffy2U3obp3GlX8H4TXD_U-rMpXvwPU7yEe7xkRUNruQ97q-_r9AqB1qp9XXLqBtUbImE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagSIgL4s1CQUbiBlbj19o-oZBSVUhFCLVSbpbX9oYItBua5NJfz9jxbhUevW3WE8nxN_Z8M57MIPRWOp4soyBSMkNE0zrSNLUnYBs9i17SkOtsn32pTy_E57mcl4DbuqRVDmdiPqhD71OM_IhJrpK9lJMPq18kdY1Kt6ulhcZtdIcCE0mtG9RcjTGWxI4NNeW_MhOuj9YCHApNUl5CJvvkas8e5bL9_-Kaf6dM_nFvms3RyQN0v_BIPN0B_xDdit0jdPes3JQ_Rm66XeRMoG6BYfGWZHZMDTyF4RNjeDb9hs9JCt3jZN4SRDjlwS_w12Pw-UBGY8DU_1j1y24DMimyhnNlh2W3foIuTj6dz05JaadAPNCyDRFRGRYDU40w4EJ7HYEMcMdM4Frpxk9qFiSwpShFU7chOy-CJ3tfgxPFAn-KDrq-i88RFo33tBXUt1qJ1nkngQZFxZWJwenYVogOi2p9qTWeWl78tPnOm2u7A8ICEDYDYa8q9G78zmpXaeNG6Y8Jq1EyVcnOL_rLhS2bzrqWKeloI71ywvvWBeMUdcob5-DsYhU6HJC2Zeuu7bWiVejNOAybLsHhuthvs4wGrqukqdCznWKMM-EwU62NqJDaU5m9qe6PdMvvubC3pir52xV6PyjX9bT-vxQvbv4VL9E9lvW9JhNxiA42l9v4CojUpnmdd8tv3GMYXQ
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB9qC-KL-O1qlQi-afA2H5vkcb1aykFFtIW-hSSbvR7KXundvfSvd5LbXTmtgm-7m1kYMpPMb5LJLwBvpeMpMgoqJTNU-NZR76tAMTYGFoMsm8yzffq5OjkXswt5sQdsOAuTi_YzpWWepofqsA8rgZmApqmgIKN0enMHDrTiFQ7Gg7qefZuNKysJE5vS9CdkJlzf8vNOFMpk_bchzD8LJX_bLc1B6PgB3O_RI6m3-j6Evdg9grun_f74Y3D1Zp7rf7o5wS5b0OlRafCpGd4YI9P6KzmjacGepKCWDENS9fucfDnCTA9lNEFLhu9Xy0W3Rpm0nkYyn8OiWz2B8-NPZ9MT2l-iQAOCsTUVURkWG6a8MJg4Bx0RAnDHTMO10j5MKtZIxEhRCl-1TU5ZBE9RvsLUiTX8Kex3yy4-ByJ8CGUrytBqJVoXnETwExVXJjZOx7aAcuhUG3qG8XTRxQ-bd7q5tltDWDSEzYawNwW8G_-52vJr_FP6Y7LVKJm4sfOH5fXc9r5iXcuUdKWXQTkRQusa41TpVDDO4YzFCjgcLG37AbuyTHKV4JicFPBmbMahlszhurjcZBmNCFdJU8CzrWOMmnDUVGsjClA7LrOj6m5Lt7jMdN66VCnLLuD94Fy_1Pp7V7z4P_GXcI9l_6_oRBzC_vp6E18hnFr71_34-QmrHBgb
  priority: 102
  providerName: Springer Nature
Title Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
URI https://link.springer.com/article/10.1038/s41408-021-00499-z
https://www.ncbi.nlm.nih.gov/pubmed/34088894
https://www.proquest.com/docview/2537006550
https://www.proquest.com/docview/2538054759
https://pubmed.ncbi.nlm.nih.gov/PMC8178409
https://doaj.org/article/af275a1b5c7a4ccfad9a71a7c9aa4002
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB71IVW9IN6klFWQuIFh49ixfUAoTVuqlVpVpSvtLXIcZ1lRZdt9SNBfz9hJFi0sHLjkYY8VyzOT-cYejwHecB07y8gI51QRVlSaFEViCNpGQ63hUenzbJ9fJGdDNhjx0RZ0xx21Azjf6Nq586SGs5v33-9-fEKF_9hsGZcf5gy9BElcsIFH8OR-G3b9epEL5WvhfpPrG92FSLV7ZzY33Ye9GIukVGzNVPmM_ptg6J_RlL8tqXpLdfoQHrQQM0wbmXgEW7Z-DHvn7SL6E9DpcuyDhOpxiOM6IdlxpPCp7N4oDbP0KrwmblY_dJbPcS90IfLj8PIY3UGkkSGy23y7nU7qBdK4SbfQJ32Y1POnMDw9uc7OSHvSAjGI2BaEWaGoLakomELv2kiLOCHWVJWxFLIw_YSWHIGU5axIqtL7NSx2UCBB_4qW8TPYqae1fQEhK4yJKhaZSgpWaaM5IiQrYqFsqaWtAoi6Qc1Nm4bcnYZxk_vl8FjmDU9y5EnueZLfB_B21ea2ScLxT-ojx6sVpUug7Qums3He6mOuKyq4jgpuhGbGVLpUWkRaGKU1_tZoAIcdp_NOKHPKY-EwG-8H8HpVjfro2KFrO116GokwWHAVwPNGMFY96QQrALEmMmtdXa-pJ199zm8ZCeeKB_CuE65f3fr7UBz894dewj71WpGQPjuEncVsaV8h_FoUPdgWI9GD3TQdfBng_ejk4vIKS7Mk6_kpDbx-HkU9r3s_AdvzMBE
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN8EBgQJnsBa49ix_TChrt20sbWapk7aW3Bsp1SgtKytEPvj-Ns4u0mn8rG3vSXxJXJ8Z9_vfOc7gLdcp14zMsI5VYQVpSZFkRmCutFQZ3hiQ57t_iA7OGOfzvn5BvxqzsL4sMpmTQwLtZ0Yv0e-TXkqvL7k7Y_T78RXjfLe1aaEhq5LK9idkGKsPthx5H7-QBNutnPYQ36_o3R_b9g9IHWVAWIQrcwJc0JRZ6komELL0kiHOjLVVNlUClmYdkYtRxDhOCuy0gZMz1KvBjO0LahN8bu3YJP5DZQWbO7uDU5OV7s8Hp-rRNWnddqp3J4xNGkk8ZERwdwgl2saMRQO-Bfa_Tto8w_PbVCI-_fhXo1k485S9B7Ahqsewu1-7at_BLqzGIVYpGoUI_vGpNtLFF7Z5o7SuNs5jYfEOw9ir2C9kMQ-En8Un_TQ6kQaGaNUma_TybiaI43f24tDbolxNXsMZzcy1E-gVU0q9wxiVhiTlCwxpRSs1EZzBGJOpEI5q6UrI0iaQc1Nne3cF934lgeveyrzJSNyZEQeGJFfRvB-9c50mevjWupdz6sVpc_THR5MLkZ5Pe1zXVLBdVJwIzQzptRWaZFoYZTWuHrSCLYaTuf14jHLr0Q9gjerZpz2nh26cpNFoJGItgVXETxdCsaqJyn2VErFIhBrIrPW1fWWavwlpBaXifAWfwQfGuG66tb_h-L59X_xGu4cDPvH-fHh4OgF3KVB9jPSZlvQml8s3EuEdfPiVT13Yvh809P1NxQ2WXU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIU28IL4JDDASPIHVxh-x_YBQaak2xqYJbVLfguM4pQKlZW2F2J_GX8fZTTqVj73tLR-XyPHd-Xfnu9wBvJCWB2QUVEpmqCgqS4sicxSx0THvZFrGOtuHR9neqfgwkqMt-NX-CxPSKts1MS7U5dSFPfIOk1wFvJTdTtWkRRwPhm9n32noIBUirW07jZWIHPifP9B9m7_ZHyCvXzI2fH_S36NNhwHq0FJZUOGVYb5kqhAGvUqnPeIjt8yUXCtduG7GSokGhJeiyKoy2vOCBwjM0K9gJcf3XoPriiOsoy6pkVrv7wTL3KSm-U-ny3VnLtCZ0TTkRERHg55vYGFsGfAvO_fvdM0_YrYRCoe34GZjw5LeSuhuw5av78DOYROlvwu2txzHLKR6TJBxE9ofpAaPyvaMMdLvfSInNIQNSIDWIB4k5OCPyfEA_U2k0QTlyX2dTSf1AmnCrh6JVSUm9fwenF7JRN-H7Xpa-4dAROFcWonUVVqJyjor0QTziivjS6t9lUDaTmrumjrnod3GtzzG27nOV4zIkRF5ZER-nsCr9TOzVZWPS6nfBV6tKUOF7nhhejbOG4XPbcWUtGkhnbLCucqWxqrUKmesxXWTJbDbcjpvlo15fiHkCTxf30aFD-ywtZ8uI41GO1tJk8CDlWCsR8JxpFobkYDaEJmNoW7eqSdfYlFxnarg6yfwuhWui2H9fyoeXf4Vz2AHlTT_uH908BhusCj6Ge2KXdhenC39E7TnFsXTqDgEPl-1pv4GqsZXGQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Augmenting+anti-CD19+and+anti-CD22+CAR+T-cell+function+using+PD-1-CD28+checkpoint+fusion+proteins&rft.jtitle=Blood+cancer+journal+%28New+York%29&rft.au=Blaeschke%2C+Franziska&rft.au=Stenger%2C+Dana&rft.au=Apfelbeck%2C+Antonia&rft.au=Cadilha%2C+Bruno+L.&rft.date=2021-06-04&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2044-5385&rft.volume=11&rft.issue=6&rft_id=info:doi/10.1038%2Fs41408-021-00499-z&rft_id=info%3Apmid%2F34088894&rft.externalDocID=PMC8178409
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-5385&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-5385&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-5385&client=summon